Recruiting NA INTERVENTIONAL 2-arm NCT07164885

RAPART in Locally Advanced Non-small Cell Lung Cancer Patients

Phase II/III Randomized Clinical Trial of Radiosensitivity-Assisted Personalized Adaptive RadioTherapy (RAPART) in Locally Advanced Non-small Cell Lung Cancer Patients

Sponsor: Capital Medical University

Conditions Locally Advanced Non-small Cell Lung Cancer

Interventions Conventional radiotherapy Radiosensitivity-Assisted Personalized Adaptive Radiotherapy Technology（RAPART)）

Updated 2 times since 2025 Last updated: Dec 1, 2025 Started: Feb 17, 2025 Primary completion: Dec 30, 2027 Completion: Dec 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Locally Advanced Non-small Cell Lung Cancer and is currently actively recruiting participants. Capital Medical University leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

2 versions recorded

Jan 2026 — Present [monthly]

Recruiting NA

Status: Active Not Recruiting → Recruiting
Oct 2025 — Jan 2026 [monthly]

Active Not Recruiting NA

First recorded

Feb 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capital Medical University

Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenzhen, China